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Two cDNA clones, I-CLFV-108 and I-CLFV-I 19, encoding for the /I-adrenergic receptor, have been tso- 
lated from a human brain stem cDNA library. One human genomic clone, LCV-517 (20 kb), was character- 
ized by restriction mapping and partial sequencing. The human brain /I-receptor consists of 413 amino acids 
with a calculated M, of 46 480. The gene contains three potential glucocorticoid receptor-binding sites. The 
p-receptor expressed in human brain was homology with rodent (88%) and avian (52%) /I-receptors and with 
porcine muscarinic cholinergic receptors (31$), supporting our proposal [( 1984) Proc. Natl. Acad. Sci. USA 
8 1, 272-2761 that adrenergic and muscarinic cholinergic receptors are structurally related. This represents 
the first cloning of a neurotransmitter receptor gene from human brain. 
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1. INTRODUCTION 
The structure and function of P-adrenergic 
receptors have been the subject of numerous in- 
vestigations during the past decade [ 1,2]. Our own 
biochemical studies have suggested that ,& 
adrenergic receptor subtypes are closely related 
proteins under both hormonal (glucocorticoid) and 
immunological regulation, findings that may have 
important implications in human disease [3-51. 
Here we describe the cloning and sequencing of 
a human brain ,&adrenergic receptor gene. This is 
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the first report on the cloning of a neurotransmit- 
ter receptor gene from human brain. By in- 
vestigating the structure and regulation of human 
neurotransmitter eceptor proteins and genes we 
hope to establish a reference point for evolutionary 
studies of neurotransmitter eceptors and to pro- 
vide a means of elucidating the role of 
neurotransmitter receptors in human disease. 
Our data, together with those of others [6,7], 
have revealed considerable conservation of fl- 
receptor structure among human, rodent and avian 
species. Furthermore, comparison of P-receptor 
protein sequence data with those from pig brain 
muscarinic cholinergic receptors [8] has 
demonstrated a high degree of homology between 
these pharmacologically unrelated receptor classes. 
These findings confirm our earlier hypothesis that 
adrenergic and muscarinic cholinergic receptors 
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share significant structural homology and strongly 
suggest that neurotransmitter eceptors may be 
part of a multigene family that evolved from a 
common ancestral gene [9- 111. 
2. MATERIALS AND METHODS 
2.1. Screening of a human brain stem cDNA 
library 
A cDNA library (LMG2) of neonatal human 
brain stem constructed in h-gt 11 (constructed by C. 
Puckett, J. Kamholz and R.A. Lazzarini and kind- 
ly provided by Dr R. Lazzarini) was screened at a 
density of about 20000 plaques per 150 mm plate 
using the bacterial host strain Y-10901-- with an 
oligonucleotide probe (51-mer) prepared from the 
C-terminus (base pair 1384-1435) of the hamster 
lung fi-adrenergic receptor cDNA sequence [6]. 
The probe was end-labeled by phosphorylation 
with [y-32P]ATP (spec. act. 3000 Ci/mmol) and T4 
polynucleotide kinase. Duplicate filters (Hybond- 
N, Amersham) were lifted from each plate, lysed 
with 0.5 M NaOH/l M NaCl, neutralized with 
1 M Tris (pH 7.4), dried and UV irradiated for 
5 min. Hybridization was carried out for 12 h at 
42°C in a solution containing 6 x SSC (1 x SSC = 
0.15 M NaCl10.015 M trisodium citrate, pH 7.0), 
5 x Denhardt’s solution, lOOpg/ml sonicated, 
heat-denatured salmon sperm DNA, 30% for- 
mamide (deionized) and 50 mM Na phosphate, pH 
7.4. Subsequent o hybridization, the filters were 
washed with 6 x SSC/O. 1% SDS for 10 min at 
room temperature followed by a 10 min wash in 
6 x SSC at 20°C. Filters were then dried and 
autoradiographed overnight using Kodak X-Omat 
AR5 film at - 70°C. Two positive clones, A- 
CLFV-108 and A-CLFV-119, were isolated from 
500000 recombinants. Their inserts were purified 
and subsequently subcloned into M 13mp 18/ 19 and 
pUC9/19 for sequence analysis and restriction 
mapping, respectively. 
2.2. Screening of a human genomic leucocyte 
library 
A human genomic leucocyte DNA library with a 
library base of 8.8 x 10’ plaques constructed in X- 
EMBL3 (Clontech, Palo Alto) was screened with 
the cDNA clone CLFV-108 (radiolabeled to a 
specific activity of 1.3 x lo* dpm/pg DNA by 
nick-translation) at a density of 25000 plaques per 
150 mm plate using the bacterial host strain 
NM538. Six positive clones, LCV-501, -508, -509, 
-510, -517 and -520 were isolated from 500000 pla- 
ques. The insert of clone LCV-517 was purified 
and further digested with the restriction enzyme 
Bg/II and the resulting fragments subcloned into 
Ml3 for sequence analysis. 
3. RESULTS AND DISCUSSION 
Screening of the human brain stem cDNA 
library with a C-terminal oligonucleotide probe 
under conditions of low stringency yielded two 
hybridizable clones, designated CLFV-108 and 
CLFV-119. Sequence analysis of the two clones 
showed that CLFV-108 (1.2 kb) and CLFV-119 
(1.1 kb) contained considerable homology with the 
hamster lung P-receptor sequence [6]. In order to 
study the genomic organization of the P-receptor 
gene we screened a human genomic leucocyte DNA 
library with the radiolabeled cDNA clone 
CLFV- 108. Six hybridizable clones were detected 
and one (designated LCV-517) was purified for 
restriction mapping and partial sequencing (fig.1). 
Sequence analysis of this genomic clone revealed 
sequence identity to cDNA clones CLFV-108 and 
119. The CLFV-108 sequence starts at base pair 
170 of the 5 ‘-coding region and extends about 
30 bp into the 3 ‘-untranslated region while the 
CLFV-119 sequence started further downstream at 
bp 750 of the coding region and contained nearly 
the whole 3 ‘-untranslated region including the 
polyadenylation site (fig.1). These data indicate 
that there are no introns in the coding or in the 
3 ’ -untranslated region of this particular gene. 
However, we cannot rule out the possibility of in- 
trons in the 5 ’ region. LCV-517 also contains at 
least bp - 177 of the 5 ‘-flanking region up to 
about 50 bp beyond the polyadenylation signal in 
the 3 ’ -untranslated region. 
The most 5’ initiation codon (nucleotides - 101 
to - 99) is followed by a TGA termination codon 
57 nucleotides downstream (nucleotides -44 to 
- 42). A second initiation codon (nucleotides l-3) 
is in the same reading frame as the first initiation 
and termination codons. The nucleotides sur- 
rounding the second initiation codon are nearly 
identical to the consensus eucaryotic initiation se- 
quence CC(A/G)CCAUGG [12] while those sur- 
rounding the first initiation codon are not similar 
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Fig. 1. Nucleotide sequence and deduced amino acid 
sequence of the human brain ,&adrenergic receptor. (A) 
Partial restriction endonuclease map and nucleotide 
sequencing strategy for the genomic clone LCV-5 17 and 
the two cDNA clones CLFV-108 and CLFV-119. The 
protein coding region is marked by the stippled box. The 
extent and direction of sequence determination are 
indicated by horizontal arrows. In most cases, 
oligonucleotides made from overlapping sequences were 
used as primers for sequence determination. DNA 
to the consensus sequence. The open reading frame 
coding for the 19 amino acids upstream from the 
proposed translation initiation site is not unique to 
the human brain P-receptor gene. Similar open 
reading frames have been reported in the mRNA 
for hamster lung P-receptor [6], pig brain 
muscarinic receptor [8] and human estrogen recep- 
tor [13]. It is not known if any of these open 
reading frames are translated. 
The open reading frame defined by the initiating 
ATG (nucleotides l-3) to the translation termina- 
tion codon TAA (nucleotides 1240-1242) codes 
for a protein of 413 amino acids. The calculated I’% 
of this polypeptide is 46480 compared with it& 
46860 for the hamster lung &receptor [6], M, 
54078 for the turkey erythrocytefl-receptor [7] and 
M, 5 1416 for the pig brain muscarinic receptor [8]. 
The human brain P-receptor has two potential 
glycosylation sites (Asn-X-Ser/Thr) at Asn6 and 
Asni5 which are conserved in the hamster lung ,& 
receptor and the pig brain muscarinic receptor. 
Only the former is conserved in the turkey 
erythrocyte &receptor. In addition, the human 
brain P-receptor has three additional sites of 
potential glycosylation at Asnz44, As~LK,~ and 
Asnmg. The latter two sites are conserved in the 
hamster lung &receptor. Which, if any, of these 
sites is actually glycosylated in the human brain @- 
receptor is not known. 
Comparison of the resulting protein sequence of 
the human brain P-receptor to those of turkey and 
hamster (fig.2) shows high homology. The extent 
of sequence identity of human brain &receptor 
with hamster lung and turkey erythrocyte & 
receptors and pig brain muscarinic receptor is 88, 
51 and 31%, respectively. When the homology is 
calculated considering favored amino acid 
substitutions the figures are 92, 68 and 46%, 
respectively. The sequence identity among all three 
sequencing was performed using the dideoxynucleotide 
chain termination method of Sanger [24] and Ml3 
bacteriophage vectors mp18 and mp19. (B) Nucleotide 
sequence and deduced amino acid of the cDNA clones 
CLFV-108 and CLFV-119 and the genomic clone 
LCV-517. The glucocorticoid-responsive lements are 
boxed. The three possible polyadenylation signals in the 
3 ’ -flanking region are marked (---). The 
polyadenylation site in clone CLFV-119 is indicated by 
the arrow. 
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Fig.2. Comparison of the deduced amino acid sequences 
of the,&adrenergic receptor from human brain, hamster 
lung [6] and turkey erythrocyte [7] and muscarinic 
receptor from pig brain [8]. The sequences were aligned 
with gaps introduced to display maximum homology by 
P-receptors is 49%) increasing to 67% when 
favored amino acid substitutions are considered. 
The degree of identity of the three &receptors and 
the pig brain muscarinic receptor sequence is 20%) 
increasing to 39% when favored amino acid 
substitutions are considered. There are six 
segments of 10 amino acids or longer which are 
conserved in all three &receptor sequences and one 
of these is also conserved in the pig brain 
muscarinic receptor. The three &receptors have 10 
conserved cysteines, 8 conserved prolines and 38 
conserved charged groups. Of these, 5 cysteines, 5 
prolines and 20 charged groups are also conserved 
in the pig brain muscarinic receptor. The con- 
served cysteines are particularly interesting in light 
of our earlier data demonstrating the presence of 
a free sulfhydryl group in the ligand-binding site of 
the dog heart @receptor as well as other evidence 
for the involvement of disulfides in the structural 
maintenance and activation of the receptor 
[14,15]. The conserved prolines and charged 
groups may also be involved in the maintenance of 
a requisite receptor structure. 
The hydropathy profile, based upon the analysis 
of Kyte and Doolittle [16], of the human brain ,& 
receptor is nearly identical to that of the hamster 
lung &receptor [6] and has features similar to 
those of the turkey &receptor [7], the pig brain 
muscarinic receptor [8] and the rhodopsins from 
human [17], cow [18], sheep [19,20], fruitfly [211 
and bacteria [22] (not shown). The overall 
homology of these proteins is shown in table 1. 
the GAP program of the University of Wisconsin 
Genetics Computer Group [25] which uses the algorithm 
of Needleman and Wunsch [26]. The alignment was 
made without bias toward putative structural domains 
of the molecules. Those amino acids which are 
conserved in all three /3-adrenergic proteins (5 
conserved) or all four proteins (M/&conserved) are 
shown below the sequences, indicated by the letter for 
that amino acid or by an asterisk if favored substitutions 
are present. Favored amino acid substitutions, as 
defined by Dayhoff [271, are those which belong to one 
of the following groups: (S,T,P,A,G), (M,I,L,V), 
(F,Y,W), (N,D,E,Q), (H,R,K) or (C). Charged groups 
and cysteines which are conserved in all three & 
adrenergic proteins are shown above the sequences. 
Those which are conserved in all four proteins are 
enclosed in parentheses. The two potential glycosylation 
sites (Asn-X-Ser/Thr) at Asna and AsnIT are indicated. 
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Fig.3. Alternative models for the polypeptide organization of the&adrenergic receptor with respect to the lipid bilayer. 
The charges hown are those of the human brain receptor. Sites of potential glycosylation are indicated. 
Models containing seven-transmembrane-spanning 
regions have been proposed for the&receptors and 
the muscarinic receptor based upon the similarity 
of these profiles to that of bacteriorhodopsin, a 
protein for which several ines of evidence support 
the notion of seven-transmembrane-sp~ning 
segments. However, this model (fig.3) contains on- 
ly minimal extracellular domains from which a 
high-affinity, stereoselective ligand-binding site 
must be formed. Fig.3 compares the seven- 
transmembrane model of the human &receptor to 
a five-transmembrane model which moves negative 
charges from presumed transmembrane segments 
and places them extracellularly, allowing for a 
putative ligand-binding domain with a greater 
degree of secondary structure. 
Three potential glucocorticoid receptor-binding 
sites or glucocorticoid-responsive elements (GRE) 
204 
are found in the human P-receptor gene sequence, 
two within the coding region (nucleotides 617-622 
and 788-793) and one closely following the stop 
codon (nucleotides 1282-1287). All three sites 
match the GRE consensus equence (T/A)GT(T/ 
C)CT although the third site is found in the an- 
tisense strand in the reverse orientation. There is 
precedent for GREs located within genes, and in 
the flanking untranslated regions in both the same 
and antisense orientation (1231 and references con- 
tained within). Thus, all three GRE sites observed 
in the human brain &receptor gene may be of 
functional importance, consistent with our 
previous data on glucocorticoid induction of 
human &adrenergic receptor synthesis (31. 
It is not clear whether the gene we have isolated 
encodes for a pi- or /3z-adrenergic receptor. The 
higher homology seen between our gene and the 
January 1987 Volume 211, number 2 FEBS LETTERS 
Table 1 
Percent homology of @-adrenergic, muscarinic and opsin proteins 
MAChR &AR Opsin 
Pig Human Hamster Turkey Human-G Human-R Human-B Cow Sheep Fruit- 
fly 
Human 31 
P-AR Hamster 31 88 
Turkey 21 52 50 
Human-G 20 22 21 19 
Human-R 20 19 22 20 96 
Human-B 18 19 20 21 43 42 
Opsin cow 22 18 25 23 43 42 44 
Sheep 22 24 27 27 43 42 42 96 
Fruitfly 21 21 21 22 30 31 27 27 25 
Bacteria 20 19 19 19 19 19 20 19 19 19 
Percent homology was calculated by the GAP program of the University of Wisconsin Genetics Computer Group [25] 
which uses the algorithm of Needleman and Wunsch [26]. Protein sequences were obtained from the following sources: 
P-AR: human brain (this study), hamster lung [6], turkey erythrocyte [7]; pig brain muscarinic receptor [8]; opsin: 
human green, red and blue [17], cow [18], sheep [19,20], fruitfly [21], bacteria [22] 
hamster lung &receptor as compared to the 
turkey erythrocyte ‘PI-like receptor could imply 
that we have cloned a human &-receptor gene. On 
the other hand, the degree of homology could 
merely reflect species variation and evolution of 
these proteins. Restriction maps of our human 
genomic clones indicate the presence of additional 
,&receptor-related sequences that hybridize with 
CLFV-108 under high stringency conditions. These 
data suggest either a genetic basis for &receptor 
heterogeneity and/or possible introns in additional 
P-receptor genes. 
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